These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Elevated plasma tricyclic levels with therapeutic doses of imipramine. Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633 [TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression]. Szymura-Oleksiak J; Wasieczko A Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375 [TBL] [Abstract][Full Text] [Related]
13. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time. Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303 [TBL] [Abstract][Full Text] [Related]
14. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder. Mavissakalian MR; Perel JM Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664 [TBL] [Abstract][Full Text] [Related]
15. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. Perry PJ; Zeilmann C; Arndt S J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678 [TBL] [Abstract][Full Text] [Related]
17. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients. Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959 [TBL] [Abstract][Full Text] [Related]